M 30 dihydrochloride is primarily used in research settings as a potent inhibitor of cell proliferation and angiogenesis. It is often studied for its potential therapeutic applications in cancer treatment, particularly in targeting tumor growth and metastasis. The compound has shown effectiveness in inhibiting key pathways involved in cancer progression, making it a valuable tool in preclinical studies. Additionally, it is utilized in biochemical assays to explore mechanisms of apoptosis and cellular signaling. Its role in modulating specific molecular targets also makes it relevant in the development of novel anticancer strategies.